Available NCATS Funding Opportunities
Wednesday, June 29, 2016
The National Center for Advancing Translational Sciences (NCATS) has several open SBIR and STTR program funding opportunities designed to help advance and commercialize translational research technologies. NCATS encourages applications in the following research areas: drug discovery and development, diagnostics and devices, bioinformatics and information technology, and clinical research.
Benefits of Applying
Funding is stable, predictable, not a loan, and non-dilutive. Small businesses retain intellectual property rights, and awardees also are eligible to access other support programs designed to help small businesses commercialize their technologies.
2016 Omnibus Solicitation
Application deadline of Sept. 6, 2016, 5:00 p.m. local time.
Small businesses, research and technology transfer organizations are eligible to apply for the 2016 Omnibus Solicitation. Applications may address any stage of translation, from target validation through pre-clinical and clinical evaluation to intervention, implementation and dissemination.
· SBIR: PA-16-302
· STTR: PA-16-303
Current Funding Opportunities
All have an application deadline of Sept. 6, 2016, 5:00 p.m. local time.
SBIR Direct to Phase II
Small businesses that have accomplished the objectives of a Phase I SBIR grant through non-SBIR funds are able to apply for SBIR direct to Phase II funding. Applicants must demonstrate the scientific and technical merit and feasibility of the prototype stage of developing a biomedical technology that has commercial potential.
· PAR-15-288: Direct Phase II SBIR Grants to Support Extended Development, Hardening, and Dissemination of Technologies in Biomedical Computing, Informatics, and Big Data Science
· PAR-14-088: Direct Phase II SBIR Grants to Support Biomedical Technology Development
SBIR Technology Transfer
This funding opportunity encourages SBIR grant applications from small business concerns for projects to transfer technology out of the NIH intramural research labs into the private sector.
Platform Delivery Technologies for Nucleic Acid Therapeutics
This funding opportunity is designed to incentivize small businesses to generate new technologies and products for delivering nucleic acids into cells and tissues for the purpose of treatment or prevention of human disease.
Development of Appropriate Pediatric Formulations and Drug Delivery Systems
Applications must address different and complementary research needs for the development of appropriate pediatric drug formulations in different age groups.
Learn more at NCATS Small Business, including eligibility requirements and research priorities. Contact NCATS SBIR and STTR today to discuss your project idea.